Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ERN1 | O75460 | 1/20 | 0.41 |
| ▸ | PTGDR2 | Q9Y5Y4 | 9/20 | 0.39 |
| ▸ | PTGDR | Q13258 | 6/20 | 0.39 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | GCGR | P47871 | 1/20 | 0.35 |
| ▸ | CEL | P19835 | 1/20 | 0.34 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7723661 | 0.81 | TSHR (0.48) | KDM4EMEN1MAPTKMT2AERN1 | |
| SCHEMBL28782645 | 0.81 | MEN1 (0.63) | KDM4EMEN1MAPTKMT2AERN1 | |
| SCHEMBL4612055 | 0.79 | MEN1 (0.60) | KDM4EMEN1MAPTKMT2AERN1 | |
| SCHEMBL11774790 | 0.76 | PTGDR2 (0.40) | KDM4EMEN1MAPTKMT2APTGDR2 | |
| SCHEMBL9249778 | 0.76 | AKR1C4 (0.53) | KDM4EMEN1MAPTKMT2APTGDR2 | |
| SCHEMBL2353146 | 0.75 | ERN1 (0.56) | KDM4EMEN1MAPTKMT2AERN1 | |
| SCHEMBL12459032 | 0.75 | PTGDR2 (0.40) | KDM4EMEN1MAPTKMT2AERN1 | |
| SCHEMBL23699810 | 0.73 | GCGR (0.46) | KDM4EMEN1MAPTKMT2APTGDR2 | |
| SCHEMBL23699825 | 0.72 | PTPN5 (0.46) | KDM4EMEN1MAPTKMT2APTGDR2 | |
| SCHEMBL23699823 | 0.72 | PTPN5 (0.46) | KDM4EMEN1MAPTKMT2APTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11225448-B2 | Method for manufacturing isopulegol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-01-18 | — | — | US | disclosed |
| US-20210238115-A1 | METHOD FOR MANUFACTURING ISOPULEGOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11225448-B2 | Method for manufacturing isopulegol | ACSL3, ACSL1, SQLE | KDM4E 3501/4885MEN1 267/4885MAPT 2330/4885 |
| US-20210238115-A1 | METHOD FOR MANUFACTURING ISOPULEGOL | ACSL3, ACSL1, SQLE | KDM4E 3501/4885MEN1 267/4885MAPT 2330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.